Literature DB >> 32787463

An overview of neuroblastoma cell lineage phenotypes and in vitro models.

Sheron Campos Cogo1, Thatyanne Gradowski Farias da Costa do Nascimento1, Fernanda de Almeida Brehm Pinhatti1, Nilton de França Junior1, Bruna Santos Rodrigues1, Luciane Regina Cavalli2,3, Selene Elifio-Esposito1.   

Abstract

This review was conducted to present the main neuroblastoma (NB) clinical characteristics and the most common genetic alterations present in these pediatric tumors, highlighting their impact in tumor cell aggressiveness behavior, including metastatic development and treatment resistance, and patients' prognosis. The distinct three NB cell lineage phenotypes, S-type, N-type, and I-type, which are characterized by unique cell surface markers and gene expression patterns, are also reviewed. Finally, an overview of the most used NB cell lines currently available for in vitro studies and their unique cellular and molecular characteristics, which should be taken into account for the selection of the most appropriate model for NB pre-clinical studies, is presented. These valuable models can be complemented by the generation of NB reprogrammed tumor cells or organoids, derived directly from patients' tumor specimens, in the direction toward personalized medicine.

Entities:  

Keywords:  Pediatric cancer; SH-SY5Y; in vitro models; neural crest tumors; neuroblastoma cell lines; tumor stem cells

Year:  2020        PMID: 32787463      PMCID: PMC7802384          DOI: 10.1177/1535370220949237

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  157 in total

Review 1.  Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors.

Authors:  P Pittoni; S Piconese; C Tripodo; M P Colombo
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

2.  ALK and MYCN: when two oncogenes are better than one.

Authors:  Zhihui Liu; Carol J Thiele
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

3.  Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.

Authors:  Daniel L Worthley; Susan L Woods; Tamsin R M Lannagan; Young K Lee; Tongtong Wang; Jatin Roper; Mark L Bettington; Lochlan Fennell; Laura Vrbanac; Lisa Jonavicius; Roshini Somashekar; Krystyna Gieniec; Miao Yang; Jia Q Ng; Nobumi Suzuki; Mari Ichinose; Josephine A Wright; Hiroki Kobayashi; Tracey L Putoczki; Yoku Hayakawa; Simon J Leedham; Helen E Abud; Ömer H Yilmaz; Julie Marker; Sonja Klebe; Pratyaksha Wirapati; Siddhartha Mukherjee; Sabine Tejpar; Barbara A Leggett; Vicki L J Whitehall
Journal:  Gut       Date:  2018-04-17       Impact factor: 23.059

4.  Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer.

Authors:  Marilia Freitas Calmon; Jana Jeschke; Wei Zhang; Mashaal Dhir; Cornelia Siebenkäs; Alexander Herrera; Hsing-Chen Tsai; Heather M O'Hagan; Emmanouil P Pappou; Craig M Hooker; Tao Fu; Kornel E Schuebel; Edward Gabrielson; Paula Rahal; James G Herman; Stephen B Baylin; Nita Ahuja
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

5.  The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.

Authors:  Marc B Godfried; Monique Veenstra; Peter v Sluis; Kathy Boon; Ronald v Asperen; Marie Christien Hermus; Barbara D C v Schaik; Tom P A Voûte; Manfred Schwab; Rogier Versteeg; Huib N Caron
Journal:  Oncogene       Date:  2002-03-27       Impact factor: 9.867

6.  CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.

Authors:  Patricia M Thompson; Takahiro Gotoh; Marleen Kok; Peter S White; Garrett M Brodeur
Journal:  Oncogene       Date:  2003-02-20       Impact factor: 9.867

7.  Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.

Authors:  Yongxin Chen; Raymond L Stallings
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

8.  Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Methods Mol Biol       Date:  2013

9.  Morphological Differentiation Towards Neuronal Phenotype of SH-SY5Y Neuroblastoma Cells by Estradiol, Retinoic Acid and Cholesterol.

Authors:  Heidi Teppola; Jertta-Riina Sarkanen; Tuula O Jalonen; Marja-Leena Linne
Journal:  Neurochem Res       Date:  2015-10-30       Impact factor: 3.996

10.  Assembly and turnover of neurofilaments in growing axonal neurites.

Authors:  Edward F Boumil; Rishel Vohnoutka; Sangmook Lee; Harish Pant; Thomas B Shea
Journal:  Biol Open       Date:  2018-01-26       Impact factor: 2.422

View more
  4 in total

1.  Silencing of long chain noncoding RNA paternally expressed gene (PEG10) inhibits the progression of neuroblastoma by regulating microRNA-449a (miR-449a)/ribosomal protein S2 (RPS2) axis.

Authors:  Jian Zhang; Wei Liu; Ping Ji; Yan Zhang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 2.  In Vitro Modeling of the Blood-Brain Barrier for the Study of Physiological Conditions and Alzheimer's Disease.

Authors:  Thomas Gabriel Schreiner; Ioana Creangă-Murariu; Bogdan Ionel Tamba; Nicolae Lucanu; Bogdan Ovidiu Popescu
Journal:  Biomolecules       Date:  2022-08-18

Review 3.  The Extracellular Matrix and Neuroblastoma Cell Communication-A Complex Interplay and Its Therapeutic Implications.

Authors:  Irena Horwacik
Journal:  Cells       Date:  2022-10-10       Impact factor: 7.666

4.  Horizontal transfer of the stemness-related markers EZH2 and GLI1 by neuroblastoma-derived extracellular vesicles in stromal cells.

Authors:  Aranzazu Villasante; Amandine Godier-Furnemont; Alberto Hernandez-Barranco; Johanne Le Coq; Jasminka Boskovic; Hector Peinado; Jaume Mora; Josep Samitier; Gordana Vunjak-Novakovic
Journal:  Transl Res       Date:  2021-07-02       Impact factor: 10.171

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.